Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

HAE – Haemonetics Corporation

Haemonetics Corporation
HAE
$71.05
Name : Haemonetics Corporation
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $3,412,788,480.00
EPSttm : 3.31
finviz dynamic chart for HAE
Haemonetics Corporation
$71.05
0.82%
$0.575

Float Short %

8.59

Margin Of Safety %

5

Put/Call OI Ratio

0.98

EPS Next Q Diff

-0.07

EPS Last/This Y

1.54

EPS This/Next Y

0.77

Price

70.4

Target Price

93.67

Analyst Recom

1.2

Performance Q

4.76

Relative Volume

0.64

Beta

0.37

Ticker: HAE




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-07HAE64.183.0793.5514715
2025-05-08HAE68.093.610.3916771
2025-05-09HAE68.23.371.2617124
2025-05-12HAE70.33.370.0317126
2025-05-13HAE69.093.300.4717217
2025-05-14HAE68.643.340.0017162
2025-05-15HAE69.423.330.6017170
2025-05-16HAE70.333.320.1117191
2025-05-19HAE69.350.960.003781
2025-05-20HAE68.950.960.003784
2025-05-21HAE66.910.960.003784
2025-05-22HAE66.140.950.223767
2025-05-23HAE66.060.950.003771
2025-05-27HAE67.980.950.753771
2025-05-28HAE67.630.963.003783
2025-05-29HAE67.890.960.073785
2025-05-30HAE67.690.950.003799
2025-06-02HAE68.810.940.803820
2025-06-03HAE69.660.910.283816
2025-06-04HAE69.690.980.003589
2025-06-05HAE70.460.980.993593
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-07HAE64.2535.671.44.55
2025-05-08HAE68.0235.680.74.55
2025-05-09HAE68.204.869.94.89
2025-05-12HAE70.234.875.24.89
2025-05-13HAE69.144.866.34.89
2025-05-14HAE68.644.852.04.89
2025-05-15HAE69.39-0.155.24.89
2025-05-16HAE70.33-0.155.84.87
2025-05-19HAE69.36-0.150.84.87
2025-05-20HAE68.91-0.152.14.87
2025-05-21HAE66.91-0.148.04.87
2025-05-22HAE66.14-0.151.24.87
2025-05-23HAE66.02-0.111.54.87
2025-05-27HAE67.99-0.117.24.87
2025-05-28HAE67.63-0.110.94.87
2025-05-29HAE67.87-0.112.64.87
2025-05-30HAE67.71-0.111.54.87
2025-06-02HAE68.81-0.114.84.87
2025-06-03HAE69.66-0.114.24.87
2025-06-04HAE69.67-0.111.94.87
2025-06-05HAE70.40-0.113.84.87
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-07HAE0.00-2.228.92
2025-05-08HAE0.00-2.228.92
2025-05-09HAE0.00-2.228.92
2025-05-12HAE0.00-1.068.77
2025-05-13HAE0.00-1.068.77
2025-05-14HAE0.00-1.068.77
2025-05-15HAE0.00-1.068.79
2025-05-16HAE0.00-1.068.79
2025-05-19HAE0.00-5.438.77
2025-05-20HAE0.00-5.438.77
2025-05-21HAE0.00-5.438.77
2025-05-22HAE0.00-5.438.77
2025-05-23HAE0.00-5.438.77
2025-05-27HAE0.00-4.819.18
2025-05-28HAE0.00-4.818.59
2025-05-29HAE0.00-4.818.59
2025-05-30HAE0.00-4.818.59
2025-06-02HAE0.00-4.698.59
2025-06-03HAE0.00-4.698.59
2025-06-04HAE0.00-4.698.59
2025-06-05HAE0.00-4.698.59
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

1.24

Avg. EPS Est. Current Quarter

1.02

Avg. EPS Est. Next Quarter

1.17

Insider Transactions

Institutional Transactions

-4.69

Beta

0.37

Average Sales Estimate Current Quarter

305

Average Sales Estimate Next Quarter

321

Fair Value

73.96

Quality Score

85

Growth Score

92

Sentiment Score

58

Actual DrawDown %

50.5

Max Drawdown 5-Year %

-68.6

Target Price

93.67

P/E

21.23

Forward P/E

12.49

PEG

1.87

P/S

2.49

P/B

4.14

P/Free Cash Flow

23.74

EPS

3.32

Average EPS Est. Cur. Y​

4.87

EPS Next Y. (Est.)

5.64

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

12.32

Relative Volume

0.64

Return on Equity vs Sector %

-3.6

Return on Equity vs Industry %

2.3

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

13.8
Haemonetics Corporation
Sector: Healthcare
Industry: Medical Devices
Employees: 3023
Haemonetics Corporation, a medical technology company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tool. It also provides treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery, among others; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE closure products comprising VASCADE 5F, VASCADE 6/7F, VASCADE MVP XL, and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, clinical specialists, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
stock quote shares HAE – Haemonetics Corporation Stock Price stock today
news today HAE – Haemonetics Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch HAE – Haemonetics Corporation yahoo finance google finance
stock history HAE – Haemonetics Corporation invest stock market
stock prices HAE premarket after hours
ticker HAE fair value insiders trading